Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
No published peer-reviewed study we can identify has run a rigorous stability trial on compounded tirzepatide in BAC water and reported a validated beyond-use date with assay data at multiple timepoints
SURMOUNT-2 (Obesity with T2D) Perhaps the most anticipated trial in the program, SURPASS-2 was a 40-week, head-to-head study comparing Tirzepatide (5, 10, and 15 mg) to the highest approved dose of the potent selective GLP-1 RA, semaglutide (1 mg), in 1,878 patients with T2D on a background of metformin
Additional information Competing interests The authors declare that they have no competing interests that would influence the content of this review
Thickening gums (xanthan, guar, cellulose gum)
